Filing Details
- Accession Number:
- 0001209191-19-026889
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-02 07:02:12
- Reporting Period:
- 2019-04-30
- Accepted Time:
- 2019-05-02 07:02:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1323885 | Atricure Inc. | ATRC | Surgical & Medical Instruments & Apparatus (3841) | 341940305 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1666600 | J Justin Noznesky | 7555 Innovation Way Mason OH 45040 | Svp, Mktg & Business Develop | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-04-30 | 15,000 | $18.30 | 119,068 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-04-30 | 15,000 | $30.00 | 104,068 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2019-04-30 | 15,000 | $0.00 | 15,000 | $18.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
45,000 | 2015-01-06 | 2024-01-06 | No | 4 | M | Direct |
Footnotes
- These shares were exercised pursuant to a 10b5-1 trading plan.
- These shares were sold pursuant to a 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $30.00 to $30.04 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- These options were granted on January 6, 2014 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.